Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ASCO 2022
The 2022 meeting of the American Society of Clinical Oncology, June 3 to 7 in Chicago.
Fierce Pharma
ASCO: Enhertu could transform breast cancer with HER2-low show
Enhertu's results in HER2-low breast cancer are “phenomenally spectacular,” said Ken Takeshita, M.D., global head of R&D at Daiichi Sankyo.
Angus Liu
Jun 5, 2022 8:00am
Promontory Therapeutics 'can't hire fast enough' amid expansion
Jun 16, 2022 12:10am
ASCO: Takeda Oncology ready to stoke partnerships
Jun 9, 2022 7:30am
ASCO: Study shows poor communication impacts trial diversity
Jun 7, 2022 10:55am
ASCO: Return to in-person 'zoo that it always was'
Jun 7, 2022 10:40am
Arcellx's CAR-T is matching J&J-Legend’s Carvykti, analyst says
Jun 6, 2022 5:05pm
